Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Sangamo Therapeutics Inc. buy Wedbush

Sangamo Therapeutics Inc.
Start price
€2.97
27.02.23 / 50%
Target price
€15.12
27.02.24
Performance (%)
-63.50%
End price
€1.08
28.02.24
Summary
This prediction ended on 28.02.24 with a price of €1.08. The BUY prediction by Wedbush for Sangamo Therapeutics Inc. performed very badly with a performance of -63.50%. Wedbush has a follow-up prediction for Sangamo Therapeutics Inc. where he still thinks Sangamo Therapeutics Inc. is a Buy. Wedbush has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Sangamo Therapeutics Inc. -12.188% -12.188% -72.018%
iShares Core DAX® -3.033% 0.651% 12.268%
iShares Nasdaq 100 -3.554% -3.007% 27.682%
iShares Nikkei 225® -3.938% 1.935% 10.515%
iShares S&P 500 -1.517% -0.602% 25.859%

Comments by Wedbush for this prediction

In the thread Sangamo Bioscienes diskutieren
Prediction Buy
Perf. (%) -63.50%
Target price 15.117
Change
Ends at 27.02.24

Sangamo Therapeutics, Inc. (NASDAQ: SGMO) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $16.00 price target on the stock.
Ratings data for SGMO provided by MarketBeat

Wedbush 
0
Report Share
27.02.23
In the thread Trading Sangamo Bioscienes
Prediction Buy
Perf. (%) -63.50%
Target price 15.117
Change
Ends at 27.02.24

Die von Wedbush gewählte maximale Laufzeit wurde überschritten

Wedbush 
0
Report Share
28.02.24

Current prediction by Wedbush for Sangamo Therapeutics Inc.

buy
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.99
11.08.23
€9.12
11.08.24
-63.03%
19.07.24

Wedbush 
11.08.23 50%